Mandate

Vinge has advised Xpray Pharma in connection with share issue

November 08, 2021 Capital Markets and Public M&A

Vinge has advised Xspray Pharma, a pharmaceutical company with several product candidates in clinical development listed on Nasdaq Stockholm, in connection with a share issue whereby the company raises proceeds of approximately SEK 100 million.

Vinge’s team consisted of Dain Hård Nevonen, Linnéa Sellström and Joel Magnusson.

Related

Vinge has advised Axcel VI and Currentum in connection with the acquisition of Klarins Rör

Vinge has advised Axcel VI and the Currentum Group in connection with the acquisition of Klarins Rör i Göteborg AB (“Klarins Rör”).
December 09, 2025

Vinge advises on the sale of RK Projektledning to Qflow

Vinge has advised the sellers in connection with the sale of all shares in RK Projektledning AB to Qflow Group.
December 05, 2025

Vinge represents IKEA Forestry Investment AB in connection with the acquisition of forest land in Latvia and Lithuania

Vinge assists IKEA Forestry Investment AB (a company within the Inter IKEA group) in the acquisition of a Latvian and a Lithuanian company from Dasos Timberland Fund II (a fund managed by CapMan Natural Capital).
December 05, 2025